APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharma & Cosmetics

Pharma is a substance of the prevention or treatment for human diseases. It can be divided into natural medicine and synthetic medicine according to the source. Pharma is a material which can prevent and treat disease, reduce pain, improve health, or enhance the body's resistance to disease or to help diagnose diseases.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Pharma is a substance of the prevention or treatment for human diseases. It can be divided into natural medicine and synthetic medicine according to the source. Pharma is a material which can prevent and treat disease, reduce pain, improve health, or enhance the body's resistance to disease or to help diagnose diseases.

Selected research

Market Outlook & Growth Opportunities

Global Pharma & Cosmetics Market Outlook and Growth Opportunities 2026

2 January 2026200 pages

Choose your research edition.

Industry ResearchPharma & Cosmetics Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharma & Cosmetics Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Pharma & Cosmetics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharma & Cosmetics Market Outlook and Growth Opportunities 2026200 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharma & Cosmetics Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

Pharma is a substance of the prevention or treatment for human diseases. It can be divided into natural medicine and synthetic medicine according to the source. Pharma is a material which can prevent and treat disease, reduce pain, improve health, or enhance the body's resistance to disease or to help diagnose diseases.

The major players in global Pharma & Cosmetics market include Johnson & Johnson, Roche, Novartis, etc., and the market concentration rate is low. China and Japan are main markets, they occupy about 40% of the global market. Pharmaceuticals, OTC is the main application, which holds a share about 75%.

This report provides an overview of the global Pharma & Cosmetics market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Pharma & Cosmetics and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pharma & Cosmetics sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pharma & Cosmetics market size, projected growth trends, production technologies, key applications, and end-use industries.

Pharma & Cosmetics Segment by Company

Johnson & Johnson

Roche

Novartis

Pfizer

Sanofi

Eli Lilly

GSK

Bayer

Merck & Co

L' OREAL

Unilever

Procter & Gamble

Estee Lauder

Kao

Shiseido

Beiersdorf

Henkel

Shanghai Jahwa

Pharma & Cosmetics Segment by Type

Ointments

Creams

Gels

Others

Pharma & Cosmetics Segment by Application

Pharmaceuticals, OTC

Cosmetics

Pharma & Cosmetics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Pharma & Cosmetics status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Pharma & Cosmetics market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pharma & Cosmetics significant trends, drivers, influence factors in global and regions.

6. To analyze Pharma & Cosmetics competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharma & Cosmetics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharma & Cosmetics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharma & Cosmetics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pharma & Cosmetics market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharma & Cosmetics industry.

Chapter 3: Detailed analysis of Pharma & Cosmetics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Pharma & Cosmetics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Pharma & Cosmetics in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pharma & Cosmetics Industry Trends Table 2. Pharma & Cosmetics Industry Drivers Table 3. Pharma & Cosmetics Industry Opportunities and Challenges Table 4. Pharma & Cosmetics Industry Restraints Table 5. Global Pharma & Cosmetics Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pharma & Cosmetics Revenue Share by Company (2021-2026) Table 7. Global Pharma & Cosmetics Sales Volume by Company (kt) & (2021-2026) Table 8. Global Pharma & Cosmetics Sales Volume Share by Company (2021-2026) Table 9. Global Pharma & Cosmetics Average Price (US$/t) of Company (2021-2026) Table 10. Global Pharma & Cosmetics Company Ranking, (2024-2026) & (USD Million) Table 11. Global Pharma & Cosmetics Key Company Manufacturing Base & Headquarters Table 12. Global Pharma & Cosmetics Company, Product Type & Application Table 13. Global Pharma & Cosmetics Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Pharma & Cosmetics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Ointments Table 18. Significant Companies of Creams Table 19. Significant Companies of Gels Table 20. Significant Companies of Others Table 21. Global Pharma & Cosmetics Sales Volume by Type 2021 VS 2025 VS 2032 (kt) Table 22. Global Pharma & Cosmetics Sales Volume by Type (2021-2026) & (kt) Table 23. Global Pharma & Cosmetics Sales Volume by Type (2027-2032) & (kt) Table 24. Global Pharma & Cosmetics Sales Volume Share by Type (2021-2026) Table 25. Global Pharma & Cosmetics Sales Volume Share by Type (2027-2032) Table 26. Global Pharma & Cosmetics Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Pharma & Cosmetics Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Pharma & Cosmetics Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Pharma & Cosmetics Sales Value Share by Type (2021-2026) Table 30. Global Pharma & Cosmetics Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Pharmaceuticals, OTC Table 32. Significant Companies of Cosmetics Table 33. Global Pharma & Cosmetics Sales Volume by Application 2021 VS 2025 VS 2032 (kt) Table 34. Global Pharma & Cosmetics Sales Volume by Application (2021-2026) & (kt) Table 35. Global Pharma & Cosmetics Sales Volume by Application (2027-2032) & (kt) Table 36. Global Pharma & Cosmetics Sales Volume Share by Application (2021-2026) Table 37. Global Pharma & Cosmetics Sales Volume Share by Application (2027-2032) Table 38. Global Pharma & Cosmetics Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Pharma & Cosmetics Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Pharma & Cosmetics Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Pharma & Cosmetics Sales Value Share by Application (2021-2026) Table 42. Global Pharma & Cosmetics Sales Value Share by Application (2027-2032) Table 43. Global Pharma & Cosmetics Sales by Region: 2021 VS 2025 VS 2032 (kt) Table 44. Global Pharma & Cosmetics Sales by Region (2021-2026) & (kt) Table 45. Global Pharma & Cosmetics Sales Market Share by Region (2021-2026) Table 46. Global Pharma & Cosmetics Sales by Region (2027-2032) & (kt) Table 47. Global Pharma & Cosmetics Sales Market Share by Region (2027-2032) Table 48. Global Pharma & Cosmetics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Pharma & Cosmetics Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Pharma & Cosmetics Sales Value Share by Region (2021-2026) Table 51. Global Pharma & Cosmetics Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Pharma & Cosmetics Sales Value Share by Region (2027-2032) Table 53. Global Pharma & Cosmetics Market Average Price (US$/t) by Region (2021-2026) Table 54. Global Pharma & Cosmetics Market Average Price (US$/t) by Region (2027-2032) Table 55. Global Pharma & Cosmetics Sales by Country: 2021 VS 2025 VS 2032 (kt) Table 56. Global Pharma & Cosmetics Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Pharma & Cosmetics Sales by Country (2021-2026) & (kt) Table 58. Global Pharma & Cosmetics Sales Market Share by Country (2021-2026) Table 59. Global Pharma & Cosmetics Sales by Country (2027-2032) & (kt) Table 60. Global Pharma & Cosmetics Sales Market Share by Country (2027-2032) Table 61. Global Pharma & Cosmetics Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Pharma & Cosmetics Sales Value Market Share by Country (2021-2026) Table 63. Global Pharma & Cosmetics Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Pharma & Cosmetics Sales Value Market Share by Country (2027-2032) Table 65. Johnson & Johnson Company Information Table 66. Johnson & Johnson Business Overview Table 67. Johnson & Johnson Pharma & Cosmetics Sales (kt), Value (US$ Million), Price (US$/t) and Gross Margin (2021-2026) Table 68. Johnson & Johnson Pharma & Cosmetics Product Portfolio Table 69. Johnson & Johnson Recent Development Table 70. Roche Company Information Table 71. Roche Business Overview Table 72. Roche Pharma & Cosmetics Sales (kt), Value (US$ Million), Price (US$/t) and Gross Margin (2021-2026) Table 73. Roche Pharma & Cosmetics Product Portfolio Table 74. Roche Recent Development Table 75. Novartis Company Information Table 76. Novartis Business Overview Table 77. Novartis Pharma & Cosmetics Sales (kt), Value (US$ Million), Price (US$/t) and Gross Margin (2021-2026) Table 78. Novartis Pharma & Cosmetics Product Portfolio Table 79. Novartis Recent Development Table 80. Pfizer Company Information Table 81. Pfizer Business Overview Table 82. Pfizer Pharma & Cosmetics Sales (kt), Value (US$ Million), Price (US$/t) and Gross Margin (2021-2026) Table 83. Pfizer Pharma & Cosmetics Product Portfolio Table 84. Pfizer Recent Development Table 85. Sanofi Company Information Table 86. Sanofi Business Overview Table 87. Sanofi Pharma & Cosmetics Sales (kt), Value (US$ Million), Price (US$/t) and Gross Margin (2021-2026) Table 88. Sanofi Pharma & Cosmetics Product Portfolio Table 89. Sanofi Recent Development Table 90. Eli Lilly Company Information Table 91. Eli Lilly Business Overview Table 92. Eli Lilly Pharma & Cosmetics Sales (kt), Value (US$ Million), Price (US$/t) and Gross Margin (2021-2026) Table 93. Eli Lilly Pharma & Cosmetics Product Portfolio Table 94. Eli Lilly Recent Development Table 95. GSK Company Information Table 96. GSK Business Overview Table 97. GSK Pharma & Cosmetics Sales (kt), Value (US$ Million), Price (US$/t) and Gross Margin (2021-2026) Table 98. GSK Pharma & Cosmetics Product Portfolio Table 99. GSK Recent Development Table 100. Bayer Company Information Table 101. Bayer Business Overview Table 102. Bayer Pharma & Cosmetics Sales (kt), Value (US$ Million), Price (US$/t) and Gross Margin (2021-2026) Table 103. Bayer Pharma & Cosmetics Product Portfolio Table 104. Bayer Recent Development Table 105. Merck & Co Company Information Table 106. Merck & Co Business Overview Table 107. Merck & Co Pharma & Cosmetics Sales (kt), Value (US$ Million), Price (US$/t) and Gross Margin (2021-2026) Table 108. Merck & Co Pharma & Cosmetics Product Portfolio Table 109. Merck & Co Recent Development Table 110. L' OREAL Company Information Table 111. L' OREAL Business Overview Table 112. L' OREAL Pharma & Cosmetics Sales (kt), Value (US$ Million), Price (US$/t) and Gross Margin (2021-2026) Table 113. L' OREAL Pharma & Cosmetics Product Portfolio Table 114. L' OREAL Recent Development Table 115. Unilever Company Information Table 116. Unilever Business Overview Table 117. Unilever Pharma & Cosmetics Sales (kt), Value (US$ Million), Price (US$/t) and Gross Margin (2021-2026) Table 118. Unilever Pharma & Cosmetics Product Portfolio Table 119. Unilever Recent Development Table 120. Procter & Gamble Company Information Table 121. Procter & Gamble Business Overview Table 122. Procter & Gamble Pharma & Cosmetics Sales (kt), Value (US$ Million), Price (US$/t) and Gross Margin (2021-2026) Table 123. Procter & Gamble Pharma & Cosmetics Product Portfolio Table 124. Procter & Gamble Recent Development Table 125. Estee Lauder Company Information Table 126. Estee Lauder Business Overview Table 127. Estee Lauder Pharma & Cosmetics Sales (kt), Value (US$ Million), Price (US$/t) and Gross Margin (2021-2026) Table 128. Estee Lauder Pharma & Cosmetics Product Portfolio Table 129. Estee Lauder Recent Development Table 130. Kao Company Information Table 131. Kao Business Overview Table 132. Kao Pharma & Cosmetics Sales (kt), Value (US$ Million), Price (US$/t) and Gross Margin (2021-2026) Table 133. Kao Pharma & Cosmetics Product Portfolio Table 134. Kao Recent Development Table 135. Shiseido Company Information Table 136. Shiseido Business Overview Table 137. Shiseido Pharma & Cosmetics Sales (kt), Value (US$ Million), Price (US$/t) and Gross Margin (2021-2026) Table 138. Shiseido Pharma & Cosmetics Product Portfolio Table 139. Shiseido Recent Development Table 140. Beiersdorf Company Information Table 141. Beiersdorf Business Overview Table 142. Beiersdorf Pharma & Cosmetics Sales (kt), Value (US$ Million), Price (US$/t) and Gross Margin (2021-2026) Table 143. Beiersdorf Pharma & Cosmetics Product Portfolio Table 144. Beiersdorf Recent Development Table 145. Henkel Company Information Table 146. Henkel Business Overview Table 147. Henkel Pharma & Cosmetics Sales (kt), Value (US$ Million), Price (US$/t) and Gross Margin (2021-2026) Table 148. Henkel Pharma & Cosmetics Product Portfolio Table 149. Henkel Recent Development Table 150. Shanghai Jahwa Company Information Table 151. Shanghai Jahwa Business Overview Table 152. Shanghai Jahwa Pharma & Cosmetics Sales (kt), Value (US$ Million), Price (US$/t) and Gross Margin (2021-2026) Table 153. Shanghai Jahwa Pharma & Cosmetics Product Portfolio Table 154. Shanghai Jahwa Recent Development Table 155. Key Raw Materials Table 156. Raw Materials Key Suppliers Table 157. Pharma & Cosmetics Distributors List Table 158. Pharma & Cosmetics Customers List Table 159. Research Programs/Design for This Report Table 160. Authors List of This Report Table 161. Secondary Sources Table 162. Primary Sources List of Figures Figure 1. Pharma & Cosmetics Product Image Figure 2. Global Pharma & Cosmetics Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharma & Cosmetics Sales Value (2021-2032) & (US$ Million) Figure 4. Global Pharma & Cosmetics Sales (2021-2032) & (kt) Figure 5. Global Pharma & Cosmetics Sales Average Price (US$/t) & (2021-2032) Figure 6. Global Pharma & Cosmetics Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Ointments Image Figure 10. Creams Image Figure 11. Gels Image Figure 12. Others Image Figure 13. Global Pharma & Cosmetics Sales Volume by Type (2021 VS 2025 VS 2032) & (kt) Figure 14. Global Pharma & Cosmetics Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Pharma & Cosmetics Sales Volume Share by Type (2021-2032) Figure 16. Global Pharma & Cosmetics Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Pharma & Cosmetics Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Pharma & Cosmetics Sales Value Share by Type (2021-2032) Figure 19. Pharmaceuticals, OTC Image Figure 20. Cosmetics Image Figure 21. Global Pharma & Cosmetics Sales Volume by Application (2021 VS 2025 VS 2032) & (kt) Figure 22. Global Pharma & Cosmetics Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Pharma & Cosmetics Sales Volume Share by Application (2021-2032) Figure 24. Global Pharma & Cosmetics Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Pharma & Cosmetics Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Pharma & Cosmetics Sales Value Share by Application (2021-2032) Figure 27. Global Pharma & Cosmetics Sales by Region: 2021 VS 2025 VS 2032 (kt) Figure 28. Global Pharma & Cosmetics Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Pharma & Cosmetics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Pharma & Cosmetics Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Pharma & Cosmetics Sales Value (2021-2032) & (US$ Million) Figure 32. North America Pharma & Cosmetics Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Pharma & Cosmetics Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Pharma & Cosmetics Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Pharma & Cosmetics Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Pharma & Cosmetics Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Pharma & Cosmetics Sales Value (2021-2032) & (US$ Million) Figure 38. South America Pharma & Cosmetics Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Pharma & Cosmetics Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Pharma & Cosmetics Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Pharma & Cosmetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Pharma & Cosmetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Pharma & Cosmetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Pharma & Cosmetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Pharma & Cosmetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Pharma & Cosmetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Pharma & Cosmetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Pharma & Cosmetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Pharma & Cosmetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Pharma & Cosmetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Pharma & Cosmetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Pharma & Cosmetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Pharma & Cosmetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Pharma & Cosmetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Pharma & Cosmetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Pharma & Cosmetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Pharma & Cosmetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Pharma & Cosmetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Pharma & Cosmetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Pharma & Cosmetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Pharma & Cosmetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Pharma & Cosmetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Pharma & Cosmetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Pharma & Cosmetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Pharma & Cosmetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Pharma & Cosmetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Pharma & Cosmetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Pharma & Cosmetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Pharma & Cosmetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Pharma & Cosmetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Pharma & Cosmetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Pharma & Cosmetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Pharma & Cosmetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Pharma & Cosmetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Pharma & Cosmetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Pharma & Cosmetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Pharma & Cosmetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Pharma & Cosmetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Pharma & Cosmetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Pharma & Cosmetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Pharma & Cosmetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Pharma & Cosmetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Pharma & Cosmetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Pharma & Cosmetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Pharma & Cosmetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Pharma & Cosmetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Pharma & Cosmetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Pharma & Cosmetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Pharma & Cosmetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Pharma & Cosmetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Pharma & Cosmetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Pharma & Cosmetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Pharma & Cosmetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Pharma & Cosmetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Pharma & Cosmetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Pharma & Cosmetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Pharma & Cosmetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Pharma & Cosmetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Pharma & Cosmetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Pharma & Cosmetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Pharma & Cosmetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Pharma & Cosmetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Pharma & Cosmetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Pharma & Cosmetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Pharma & Cosmetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Pharma & Cosmetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Pharma & Cosmetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Pharma & Cosmetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Pharma & Cosmetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Pharma & Cosmetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Pharma & Cosmetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Pharma & Cosmetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Pharma & Cosmetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Pharma & Cosmetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Pharma & Cosmetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Pharma & Cosmetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Pharma & Cosmetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Pharma & Cosmetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Pharma & Cosmetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Pharma & Cosmetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Pharma & Cosmetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Pharma & Cosmetics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Pharma & Cosmetics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Pharma & Cosmetics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Pharma & Cosmetics Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Pharma & Cosmetics Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Ointments
  • Creams
  • Gels
  • Others
Applications
  • Pharmaceuticals, OTC
  • Cosmetics
Companies covered
  • Johnson & Johnson
  • Roche
  • Novartis
  • Pfizer
  • Sanofi
  • Eli Lilly
  • GSK
  • Bayer
  • Merck & Co
  • L' OREAL
  • Unilever
  • Procter & Gamble
  • Estee Lauder
  • Kao
  • Shiseido
  • Beiersdorf
  • Henkel
  • Shanghai Jahwa

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pharma & Cosmetics Sales Value (2021-2032)
  4. 1.2.2 Global Pharma & Cosmetics Sales Volume (2021-2032)
  5. 1.2.3 Global Pharma & Cosmetics Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Pharma & Cosmetics Market Dynamics
  1. 2.1 Pharma & Cosmetics Industry Trends
  2. 2.2 Pharma & Cosmetics Industry Drivers
  3. 2.3 Pharma & Cosmetics Industry Opportunities and Challenges
  4. 2.4 Pharma & Cosmetics Industry Restraints
3 Pharma & Cosmetics Market by Company
  1. 3.1 Global Pharma & Cosmetics Company Revenue Ranking in 2025
  2. 3.2 Global Pharma & Cosmetics Revenue by Company (2021-2026)
  3. 3.3 Global Pharma & Cosmetics Sales Volume by Company (2021-2026)
  4. 3.4 Global Pharma & Cosmetics Average Price by Company (2021-2026)
  5. 3.5 Global Pharma & Cosmetics Company Ranking (2024-2026)
  6. 3.6 Global Pharma & Cosmetics Company Manufacturing Base and Headquarters
  7. 3.7 Global Pharma & Cosmetics Company Product Type and Application
  8. 3.8 Global Pharma & Cosmetics Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Pharma & Cosmetics Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Pharma & Cosmetics Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Pharma & Cosmetics Market by Type
  1. 4.1 Pharma & Cosmetics Type Introduction
  2. 4.1.1 Ointments
  3. 4.1.2 Creams
  4. 4.1.3 Gels
  5. 4.1.4 Others
  6. 4.2 Global Pharma & Cosmetics Sales Volume by Type
  7. 4.2.1 Global Pharma & Cosmetics Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Pharma & Cosmetics Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Pharma & Cosmetics Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Pharma & Cosmetics Sales Value by Type
  11. 4.3.1 Global Pharma & Cosmetics Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Pharma & Cosmetics Sales Value by Type (2021-2032)
  13. 4.3.3 Global Pharma & Cosmetics Sales Value Share by Type (2021-2032)
5 Pharma & Cosmetics Market by Application
  1. 5.1 Pharma & Cosmetics Application Introduction
  2. 5.1.1 Pharmaceuticals, OTC
  3. 5.1.2 Cosmetics
  4. 5.2 Global Pharma & Cosmetics Sales Volume by Application
  5. 5.2.1 Global Pharma & Cosmetics Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Pharma & Cosmetics Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Pharma & Cosmetics Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Pharma & Cosmetics Sales Value by Application
  9. 5.3.1 Global Pharma & Cosmetics Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Pharma & Cosmetics Sales Value by Application (2021-2032)
  11. 5.3.3 Global Pharma & Cosmetics Sales Value Share by Application (2021-2032)
6 Pharma & Cosmetics Regional Sales and Value Analysis
  1. 6.1 Global Pharma & Cosmetics Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pharma & Cosmetics Sales by Region (2021-2032)
  3. 6.2.1 Global Pharma & Cosmetics Sales by Region: 2021-2026
  4. 6.2.2 Global Pharma & Cosmetics Sales by Region (2027-2032)
  5. 6.3 Global Pharma & Cosmetics Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Pharma & Cosmetics Sales Value by Region (2021-2032)
  7. 6.4.1 Global Pharma & Cosmetics Sales Value by Region: 2021-2026
  8. 6.4.2 Global Pharma & Cosmetics Sales Value by Region (2027-2032)
  9. 6.5 Global Pharma & Cosmetics Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Pharma & Cosmetics Sales Value (2021-2032)
  12. 6.6.2 North America Pharma & Cosmetics Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Pharma & Cosmetics Sales Value (2021-2032)
  15. 6.7.2 Europe Pharma & Cosmetics Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Pharma & Cosmetics Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Pharma & Cosmetics Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Pharma & Cosmetics Sales Value (2021-2032)
  21. 6.9.2 South America Pharma & Cosmetics Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Pharma & Cosmetics Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Pharma & Cosmetics Sales Value Share by Country, 2025 VS 2032
7 Pharma & Cosmetics Country-level Sales and Value Analysis
  1. 7.1 Global Pharma & Cosmetics Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pharma & Cosmetics Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Pharma & Cosmetics Sales by Country (2021-2032)
  4. 7.3.1 Global Pharma & Cosmetics Sales by Country (2021-2026)
  5. 7.3.2 Global Pharma & Cosmetics Sales by Country (2027-2032)
  6. 7.4 Global Pharma & Cosmetics Sales Value by Country (2021-2032)
  7. 7.4.1 Global Pharma & Cosmetics Sales Value by Country (2021-2026)
  8. 7.4.2 Global Pharma & Cosmetics Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Pharma & Cosmetics Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Pharma & Cosmetics Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Pharma & Cosmetics Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Pharma & Cosmetics Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Pharma & Cosmetics Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Pharma & Cosmetics Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Pharma & Cosmetics Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Pharma & Cosmetics Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Pharma & Cosmetics Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Pharma & Cosmetics Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Pharma & Cosmetics Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Pharma & Cosmetics Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Pharma & Cosmetics Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Pharma & Cosmetics Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Pharma & Cosmetics Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Pharma & Cosmetics Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Pharma & Cosmetics Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Pharma & Cosmetics Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Pharma & Cosmetics Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Pharma & Cosmetics Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Pharma & Cosmetics Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Pharma & Cosmetics Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Pharma & Cosmetics Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Pharma & Cosmetics Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Pharma & Cosmetics Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Pharma & Cosmetics Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Pharma & Cosmetics Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Pharma & Cosmetics Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Pharma & Cosmetics Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Pharma & Cosmetics Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Pharma & Cosmetics Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Pharma & Cosmetics Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Pharma & Cosmetics Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Pharma & Cosmetics Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Pharma & Cosmetics Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Pharma & Cosmetics Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Pharma & Cosmetics Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Pharma & Cosmetics Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Pharma & Cosmetics Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Pharma & Cosmetics Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Pharma & Cosmetics Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Pharma & Cosmetics Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Pharma & Cosmetics Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Pharma & Cosmetics Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Pharma & Cosmetics Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Pharma & Cosmetics Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Pharma & Cosmetics Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Pharma & Cosmetics Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Pharma & Cosmetics Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Pharma & Cosmetics Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Pharma & Cosmetics Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Pharma & Cosmetics Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Pharma & Cosmetics Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Pharma & Cosmetics Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Pharma & Cosmetics Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Pharma & Cosmetics Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Pharma & Cosmetics Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Pharma & Cosmetics Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Pharma & Cosmetics Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Pharma & Cosmetics Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Pharma & Cosmetics Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Pharma & Cosmetics Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Pharma & Cosmetics Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Pharma & Cosmetics Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Pharma & Cosmetics Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Pharma & Cosmetics Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Pharma & Cosmetics Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Pharma & Cosmetics Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Pharma & Cosmetics Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Pharma & Cosmetics Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Pharma & Cosmetics Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Pharma & Cosmetics Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Pharma & Cosmetics Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Pharma & Cosmetics Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Pharma & Cosmetics Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Pharma & Cosmetics Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Pharma & Cosmetics Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Pharma & Cosmetics Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Pharma & Cosmetics Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Pharma & Cosmetics Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Pharma & Cosmetics Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Pharma & Cosmetics Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Pharma & Cosmetics Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Pharma & Cosmetics Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Johnson & Johnson
  2. 8.1.1 Johnson & Johnson Company Information
  3. 8.1.2 Johnson & Johnson Business Overview
  4. 8.1.3 Johnson & Johnson Pharma & Cosmetics Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Johnson & Johnson Pharma & Cosmetics Product Portfolio
  6. 8.1.5 Johnson & Johnson Recent Developments
  7. 8.2 Roche
  8. 8.2.1 Roche Company Information
  9. 8.2.2 Roche Business Overview
  10. 8.2.3 Roche Pharma & Cosmetics Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Roche Pharma & Cosmetics Product Portfolio
  12. 8.2.5 Roche Recent Developments
  13. 8.3 Novartis
  14. 8.3.1 Novartis Company Information
  15. 8.3.2 Novartis Business Overview
  16. 8.3.3 Novartis Pharma & Cosmetics Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Novartis Pharma & Cosmetics Product Portfolio
  18. 8.3.5 Novartis Recent Developments
  19. 8.4 Pfizer
  20. 8.4.1 Pfizer Company Information
  21. 8.4.2 Pfizer Business Overview
  22. 8.4.3 Pfizer Pharma & Cosmetics Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Pfizer Pharma & Cosmetics Product Portfolio
  24. 8.4.5 Pfizer Recent Developments
  25. 8.5 Sanofi
  26. 8.5.1 Sanofi Company Information
  27. 8.5.2 Sanofi Business Overview
  28. 8.5.3 Sanofi Pharma & Cosmetics Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Sanofi Pharma & Cosmetics Product Portfolio
  30. 8.5.5 Sanofi Recent Developments
  31. 8.6 Eli Lilly
  32. 8.6.1 Eli Lilly Company Information
  33. 8.6.2 Eli Lilly Business Overview
  34. 8.6.3 Eli Lilly Pharma & Cosmetics Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Eli Lilly Pharma & Cosmetics Product Portfolio
  36. 8.6.5 Eli Lilly Recent Developments
  37. 8.7 GSK
  38. 8.7.1 GSK Company Information
  39. 8.7.2 GSK Business Overview
  40. 8.7.3 GSK Pharma & Cosmetics Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 GSK Pharma & Cosmetics Product Portfolio
  42. 8.7.5 GSK Recent Developments
  43. 8.8 Bayer
  44. 8.8.1 Bayer Company Information
  45. 8.8.2 Bayer Business Overview
  46. 8.8.3 Bayer Pharma & Cosmetics Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Bayer Pharma & Cosmetics Product Portfolio
  48. 8.8.5 Bayer Recent Developments
  49. 8.9 Merck & Co
  50. 8.9.1 Merck & Co Company Information
  51. 8.9.2 Merck & Co Business Overview
  52. 8.9.3 Merck & Co Pharma & Cosmetics Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Merck & Co Pharma & Cosmetics Product Portfolio
  54. 8.9.5 Merck & Co Recent Developments
  55. 8.10 L' OREAL
  56. 8.10.1 L' OREAL Company Information
  57. 8.10.2 L' OREAL Business Overview
  58. 8.10.3 L' OREAL Pharma & Cosmetics Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 L' OREAL Pharma & Cosmetics Product Portfolio
  60. 8.10.5 L' OREAL Recent Developments
  61. 8.11 Unilever
  62. 8.11.1 Unilever Company Information
  63. 8.11.2 Unilever Business Overview
  64. 8.11.3 Unilever Pharma & Cosmetics Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Unilever Pharma & Cosmetics Product Portfolio
  66. 8.11.5 Unilever Recent Developments
  67. 8.12 Procter & Gamble
  68. 8.12.1 Procter & Gamble Company Information
  69. 8.12.2 Procter & Gamble Business Overview
  70. 8.12.3 Procter & Gamble Pharma & Cosmetics Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Procter & Gamble Pharma & Cosmetics Product Portfolio
  72. 8.12.5 Procter & Gamble Recent Developments
  73. 8.13 Estee Lauder
  74. 8.13.1 Estee Lauder Company Information
  75. 8.13.2 Estee Lauder Business Overview
  76. 8.13.3 Estee Lauder Pharma & Cosmetics Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Estee Lauder Pharma & Cosmetics Product Portfolio
  78. 8.13.5 Estee Lauder Recent Developments
  79. 8.14 Kao
  80. 8.14.1 Kao Company Information
  81. 8.14.2 Kao Business Overview
  82. 8.14.3 Kao Pharma & Cosmetics Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Kao Pharma & Cosmetics Product Portfolio
  84. 8.14.5 Kao Recent Developments
  85. 8.15 Shiseido
  86. 8.15.1 Shiseido Company Information
  87. 8.15.2 Shiseido Business Overview
  88. 8.15.3 Shiseido Pharma & Cosmetics Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Shiseido Pharma & Cosmetics Product Portfolio
  90. 8.15.5 Shiseido Recent Developments
  91. 8.16 Beiersdorf
  92. 8.16.1 Beiersdorf Company Information
  93. 8.16.2 Beiersdorf Business Overview
  94. 8.16.3 Beiersdorf Pharma & Cosmetics Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Beiersdorf Pharma & Cosmetics Product Portfolio
  96. 8.16.5 Beiersdorf Recent Developments
  97. 8.17 Henkel
  98. 8.17.1 Henkel Company Information
  99. 8.17.2 Henkel Business Overview
  100. 8.17.3 Henkel Pharma & Cosmetics Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Henkel Pharma & Cosmetics Product Portfolio
  102. 8.17.5 Henkel Recent Developments
  103. 8.18 Shanghai Jahwa
  104. 8.18.1 Shanghai Jahwa Company Information
  105. 8.18.2 Shanghai Jahwa Business Overview
  106. 8.18.3 Shanghai Jahwa Pharma & Cosmetics Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Shanghai Jahwa Pharma & Cosmetics Product Portfolio
  108. 8.18.5 Shanghai Jahwa Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pharma & Cosmetics Value Chain Analysis
  2. 9.1.1 Pharma & Cosmetics Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pharma & Cosmetics Sales Mode & Process
  6. 9.2 Pharma & Cosmetics Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pharma & Cosmetics Distributors
  9. 9.2.3 Pharma & Cosmetics Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst